Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.
Steinkamp MP, O'Mahony OA, Brogley M, Rehman H, Lapensee EW, Dhanasekaran S, Hofer MD, Kuefer R, Chinnaiyan A, Rubin MA, Pienta KJ, Robins DM.
Steinkamp MP, et al. Among authors: robins dm.
Cancer Res. 2009 May 15;69(10):4434-42. doi: 10.1158/0008-5472.CAN-08-3605. Epub 2009 Apr 14.
Cancer Res. 2009.
PMID: 19366804
Free PMC article.